Last updated on January 2019

BELOVA Data Collection: Safety and Efficacy of Frontline Bevacizumab Treatment in Participants With Ovarian Cancer 70 Years and Older

Brief description of study

The purpose of this study is to evaluate the safety and efficacy in the frontline treatment of ovarian cancer in participants 70 years of age and older in routine clinical practice in Belgium. Bevacizumab will be used in combination with carboplatin/paclitaxel followed by bevacizumab as maintenance in accordance with the Summary of Product Characteristics (SmPC).

Clinical Study Identifier: NCT02393898

Contact Investigators or Research Sites near you

Start Over

Reference Study ID Number: ML29515 ...

Sint Augustinus Wilrijk
Wilrijk, Belgium

Reference Study ID Number: ML29515 ...

UZ Antwerpen
Edegem, Belgium

Reference Study ID Number: ML29515 ...

AZ Nikolaas (Sint Niklaas)
Sint Niklaas, Belgium

Recruitment Status: Closed

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.